Forskning ved Københavns Universitet - Københavns Universitet

Forside

Value of internal limiting membrane peeling in surgery for idiopathic macular hole stage 2 and 3: a randomised clinical trial

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Value of internal limiting membrane peeling in surgery for idiopathic macular hole stage 2 and 3: a randomised clinical trial. / Christensen, U C; Krøyer, K; Sander, B; Larsen, M; Henning, V; Villumsen, J; la Cour, M.

I: British Journal of Ophthalmology, Bind 93, Nr. 8, 01.08.2009, s. 1005-15.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Christensen, UC, Krøyer, K, Sander, B, Larsen, M, Henning, V, Villumsen, J & la Cour, M 2009, 'Value of internal limiting membrane peeling in surgery for idiopathic macular hole stage 2 and 3: a randomised clinical trial', British Journal of Ophthalmology, bind 93, nr. 8, s. 1005-15. https://doi.org/10.1136/bjo.2008.151266, https://doi.org/10.1136/bjo.2008.151266

APA

Christensen, U. C., Krøyer, K., Sander, B., Larsen, M., Henning, V., Villumsen, J., & la Cour, M. (2009). Value of internal limiting membrane peeling in surgery for idiopathic macular hole stage 2 and 3: a randomised clinical trial. British Journal of Ophthalmology, 93(8), 1005-15. https://doi.org/10.1136/bjo.2008.151266, https://doi.org/10.1136/bjo.2008.151266

Vancouver

Christensen UC, Krøyer K, Sander B, Larsen M, Henning V, Villumsen J o.a. Value of internal limiting membrane peeling in surgery for idiopathic macular hole stage 2 and 3: a randomised clinical trial. British Journal of Ophthalmology. 2009 aug 1;93(8):1005-15. https://doi.org/10.1136/bjo.2008.151266, https://doi.org/10.1136/bjo.2008.151266

Author

Christensen, U C ; Krøyer, K ; Sander, B ; Larsen, M ; Henning, V ; Villumsen, J ; la Cour, M. / Value of internal limiting membrane peeling in surgery for idiopathic macular hole stage 2 and 3: a randomised clinical trial. I: British Journal of Ophthalmology. 2009 ; Bind 93, Nr. 8. s. 1005-15.

Bibtex

@article{0253774088ca11df928f000ea68e967b,
title = "Value of internal limiting membrane peeling in surgery for idiopathic macular hole stage 2 and 3: a randomised clinical trial",
abstract = "AIM: To determine the effect of internal limiting membrane (ILM) peeling on anatomical and functional success rates in stage 2 and 3 idiopathic macular hole surgery (MHS). METHODS: Randomised clinical trial of stage 2 and 3 idiopathic macular hole without visible epiretinal fibrosis and with less than 1 year's duration of symptoms. Eyes were randomised to (1) vitrectomy alone without retinal surface manipulation, (2) vitrectomy plus 0.05{\%} isotonic Indocyanine Green (ICG)-assisted ILM peeling or (3) vitrectomy plus 0.15{\%} Trypan Blue (TB)-assisted ILM peeling. Main outcomes were hole closure after 3 and 12 months and best-corrected visual acuity after 12 months. RESULTS: 78 eyes were enrolled. Primary closure rates were significantly higher with ILM peeling than without peeling for both stage 2 holes (ICG peeling 100{\%}, non-peeling 55{\%}, p = 0.014) and for stage 3 holes (ICG peeling 91{\%}, TB peeling 89{\%}, non-peeling 36{\%}, p",
author = "Christensen, {U C} and K Kr{\o}yer and B Sander and M Larsen and V Henning and J Villumsen and {la Cour}, M",
note = "Keywords: Aged; Coloring Agents; Epiretinal Membrane; Female; Follow-Up Studies; Humans; Indocyanine Green; Male; Middle Aged; Postoperative Complications; Retinal Perforations; Treatment Outcome; Trypan Blue; Visual Acuity; Vitrectomy",
year = "2009",
month = "8",
day = "1",
doi = "10.1136/bjo.2008.151266",
language = "English",
volume = "93",
pages = "1005--15",
journal = "British Journal of Ophthalmology",
issn = "0007-1161",
publisher = "B M J Group",
number = "8",

}

RIS

TY - JOUR

T1 - Value of internal limiting membrane peeling in surgery for idiopathic macular hole stage 2 and 3: a randomised clinical trial

AU - Christensen, U C

AU - Krøyer, K

AU - Sander, B

AU - Larsen, M

AU - Henning, V

AU - Villumsen, J

AU - la Cour, M

N1 - Keywords: Aged; Coloring Agents; Epiretinal Membrane; Female; Follow-Up Studies; Humans; Indocyanine Green; Male; Middle Aged; Postoperative Complications; Retinal Perforations; Treatment Outcome; Trypan Blue; Visual Acuity; Vitrectomy

PY - 2009/8/1

Y1 - 2009/8/1

N2 - AIM: To determine the effect of internal limiting membrane (ILM) peeling on anatomical and functional success rates in stage 2 and 3 idiopathic macular hole surgery (MHS). METHODS: Randomised clinical trial of stage 2 and 3 idiopathic macular hole without visible epiretinal fibrosis and with less than 1 year's duration of symptoms. Eyes were randomised to (1) vitrectomy alone without retinal surface manipulation, (2) vitrectomy plus 0.05% isotonic Indocyanine Green (ICG)-assisted ILM peeling or (3) vitrectomy plus 0.15% Trypan Blue (TB)-assisted ILM peeling. Main outcomes were hole closure after 3 and 12 months and best-corrected visual acuity after 12 months. RESULTS: 78 eyes were enrolled. Primary closure rates were significantly higher with ILM peeling than without peeling for both stage 2 holes (ICG peeling 100%, non-peeling 55%, p = 0.014) and for stage 3 holes (ICG peeling 91%, TB peeling 89%, non-peeling 36%, p

AB - AIM: To determine the effect of internal limiting membrane (ILM) peeling on anatomical and functional success rates in stage 2 and 3 idiopathic macular hole surgery (MHS). METHODS: Randomised clinical trial of stage 2 and 3 idiopathic macular hole without visible epiretinal fibrosis and with less than 1 year's duration of symptoms. Eyes were randomised to (1) vitrectomy alone without retinal surface manipulation, (2) vitrectomy plus 0.05% isotonic Indocyanine Green (ICG)-assisted ILM peeling or (3) vitrectomy plus 0.15% Trypan Blue (TB)-assisted ILM peeling. Main outcomes were hole closure after 3 and 12 months and best-corrected visual acuity after 12 months. RESULTS: 78 eyes were enrolled. Primary closure rates were significantly higher with ILM peeling than without peeling for both stage 2 holes (ICG peeling 100%, non-peeling 55%, p = 0.014) and for stage 3 holes (ICG peeling 91%, TB peeling 89%, non-peeling 36%, p

U2 - 10.1136/bjo.2008.151266

DO - 10.1136/bjo.2008.151266

M3 - Journal article

C2 - 19028741

VL - 93

SP - 1005

EP - 1015

JO - British Journal of Ophthalmology

JF - British Journal of Ophthalmology

SN - 0007-1161

IS - 8

ER -

ID: 20648826